RÉSUMÉ
Esophageal adenoid cystic carcinoma (EACC) is an exceedingly rare malignant tumor constituting only 0.2% of all esophageal tumors. The tumor exhibits aggressive behavior, composed histologically of ductal and modified myoepithelial cells. We report a case of a 69-year-old female with a diagnosis of an EACC by preoperative endoscopic biopsy. Thoracoscopy esophagectomy was carried out. However, pleural metastasis was found. Therefore, surgical resection of the esophageal tumor was not carried out. The patient underwent an uneventful recovery, followed by palliative treatment and ongoing chemoradiotherapy. EACC is uncommon but exhibits a more aggressive nature compared to its counterparts in the head and neck region. Dysphagia associated with gastroesophageal reflux disease is a common symptom. The duration from symptom onset to diagnosis is typically short. Treatment options include surgical resection, chemotherapy, and radiotherapy, with surgery being the preferred initial approach despite high operative mortality. Prognosis remains inconclusive, with some studies associating poor outcomes with lymph node metastasis and vascular invasion, while others report better survival rates. EACC presents diagnostic and therapeutic challenges due to its rarity and aggressive nature. Prognostic considerations remain unclear, emphasizing the need for further research and accumulated cases to delineate optimal treatment. The presented case demonstrates a 1-year survival with systemic palliative care, contributing to the evolving knowledge surrounding EACC.
El carcinoma adenoide quístico primario de esófago (EACC) es un tumor maligno excepcionalmente raro que constituye solo el 0.2% de todos los tumores esofágicos. El tumor exhibe un comportamiento agresivo, compuesto histológicamente por células ductales y mioepiteliales modificadas. Presentamos el caso de una mujer de 69 años con diagnóstico de un EACC mediante biopsia endoscópica preoperatoria. Se realizó una esofagectomía por toracoscopia. Sin embargo, se encontró metástasis pleural. Por lo tanto, no se llevó a cabo la resección quirúrgica del tumor esofágico. La paciente tuvo una recuperación sin complicaciones, seguida de tratamiento paliativo y radioquimioterapia continua. El EACC es poco común, pero exhibe una naturaleza más agresiva en comparación con sus contrapartes en la región de la cabeza y el cuello. La disfagia asociada con la enfermedad por reflujo gastroesofágico es un síntoma común. La duración desde el inicio de los síntomas hasta el diagnóstico suele ser corta. Las opciones de tratamiento incluyen la cirugía, quimio y radioterapia, siendo la cirugía la preferida a pesar de la alta mortalidad operatoria. El pronóstico es inconcluso, algunos estudios asocian resultados pobres con metástasis e invasión vascular, mientras que otros informan mejores tasas de supervivencia. El EACC presenta desafíos diagnósticos y terapéuticos debido a su rareza y naturaleza agresiva. El pronóstico sigue siendo poco claro, lo que enfatiza la necesidad de más investigación para delinear el tratamiento óptimo. El caso presentado demuestra una supervivencia de un año con cuidados paliativos sistémicos, contribuyendo al conocimiento en evolución sobre el EACC.
Sujet(s)
Carcinome adénoïde kystique , Tumeurs de l'oesophage , Humains , Carcinome adénoïde kystique/anatomopathologie , Carcinome adénoïde kystique/thérapie , Femelle , Sujet âgé , Tumeurs de l'oesophage/anatomopathologie , Tumeurs de l'oesophage/thérapie , Oesophagectomie , BiopsieRÉSUMÉ
OBJECTIVE: To evaluate and compare the expression of E-cadherin, Snail1 and Twist1 in pleomorphic adenomas (PAs), adenoid cystic carcinomas (AdCCa) and carcinoma ex-pleomorphic adenomas (CaexPA) of salivary glands, as well as investigate possible associations with clinicopathological parameters. STUDY DESIGN: E-cadherin, Snail1 and Twist1 antibody immunostaining were analyzed semiquantitatively in 20 PAs, 20 AdCCas and 10 CaexPAs. Cases were classified as low and high expression for analysis of the association with clinicopathological parameters. RESULTS: Compared to PAs, AdCCas and CaexPAs exhibited higher nuclear expression of Snail1 (p = 0.021 and p = 0.028, respectively) and Twist1 (p = 0.009 and p = 0.001). Membranous and cytoplasmic expression of E-cadherin were positively correlated in PAs, AdCCas and CaexPAs (r = 0.645, p = 0.002; r = 0.824, p < 0.001; r = 0.677, p = 0.031). In PAs, positive correlation was found between nuclear expression of Snail1 and membrane expression of E-cadherin (r = 0.634; p = 0.003), as well as between nuclear expression of Snail1 and Twist1 (r = 0.580; p = 0.007). Negative correlations were detected between membrane expression of E-cadherin and cytoplasmic expression of Snail1 in AdCCas (r = - 0.489; p = 0.029). CONCLUSIONS: E-cadherin, Twist1, and Snail1 may participate in modulating events related to cell differentiation and adhesion in PAs and to biological behavior in AdCCas and CaexPAs, which indicates the involvement of EMT in these processes. Furthermore, the expression of these proteins in these carcinomas may reflect the plasticity feature of EMT.
Sujet(s)
Adénome pléomorphe , Cadhérines , Carcinome adénoïde kystique , Transition épithélio-mésenchymateuse , Protéines nucléaires , Tumeurs des glandes salivaires , Facteurs de transcription de la famille Snail , Protéine-1 apparentée à Twist , Humains , Tumeurs des glandes salivaires/anatomopathologie , Tumeurs des glandes salivaires/métabolisme , Facteurs de transcription de la famille Snail/métabolisme , Cadhérines/métabolisme , Femelle , Mâle , Protéine-1 apparentée à Twist/métabolisme , Adulte d'âge moyen , Carcinome adénoïde kystique/anatomopathologie , Carcinome adénoïde kystique/métabolisme , Protéines nucléaires/métabolisme , Adulte , Adénome pléomorphe/métabolisme , Adénome pléomorphe/anatomopathologie , Sujet âgé , Facteurs de transcription Twist/métabolisme , Immunohistochimie , Facteurs de transcription/métabolisme , Marqueurs biologiques tumoraux/métabolismeRÉSUMÉ
BACKGROUND: Salivary gland tumors (SGTs) are rare and highly heterogeneous lesions, making diagnosis a challenging activity. In addition, the small number of studies and samples evaluated difficults the determination of prognosis and diagnosis. Despite the solid advances achieved by research, there is still an intense need to investigate biomarkers for diagnosis, prognosis and that explain the evolution and progression of SGTs. METHODS: We performed a comprehensive literature review of the molecular alterations focusing on the most frequent malignant SGTs: mucoepidermoid carcinoma and adenoid cystic carcinoma. RESULTS: Due to the importance of biomarkers in the tumorigenenic process, this review aimed to address the mechanisms involved and to describe molecular and biomarker pathways to better understand some aspects of the pathophysiology of salivary gland tumorigenesis. CONCLUSIONS: Molecular analysis is essential not only to improve the diagnosis and prognosis of the tumors but also to identify novel driver pathways in the precision medicine scenario.
Sujet(s)
Marqueurs biologiques tumoraux , Carcinome adénoïde kystique , Carcinome mucoépidermoïde , Tumeurs des glandes salivaires , Carcinome mucoépidermoïde/anatomopathologie , Carcinome mucoépidermoïde/diagnostic , Humains , Carcinome adénoïde kystique/anatomopathologie , Carcinome adénoïde kystique/diagnostic , Tumeurs des glandes salivaires/anatomopathologie , Tumeurs des glandes salivaires/diagnostic , Marqueurs biologiques tumoraux/analyseRÉSUMÉ
The aim of this study was to evaluate the expression of the EZH2 protein and describe the clinical and microscopic characteristics of adenoid cystic carcinoma (ACC) and pleomorphic adenoma (PA). The study included 16 ACC cases and 12 PA. All ACC and PA cases were positive for EZH2 and the ACC samples showed significantly higher EZH2 expression. The clinical and microscopic covariates were described in relation to EZH2 staining in ACC samples. The highest mean values of EZH2 were observed in cases with local metastasis, recurrence, perineural invasion, and predominantly cribriform growth pattern without solid areas. EZH2 is a potential marker of malignancy.
Sujet(s)
Adénome pléomorphe , Carcinome adénoïde kystique , Humains , Cycle cellulaire , Prolifération cellulaire , Protéine-2 homologue de l'activateur de ZesteRÉSUMÉ
OBJECTIVE: Pleomorphic adenoma (PA), mucoepidermoid carcinoma (MEC), and adenoid cystic carcinoma (ACC) are the most prevalent salivary gland tumors. Their pathogenesis has been recently associated with complex molecular cascades, including the TGFß signaling pathway. The aim of this study was to evaluate the expression of genes associated with the TGFß signaling pathway (TGFB1, ITGB6, SMAD2, SMAD4, FBN1, LTBP1, and c-MYC) to map possible downstream alterations in the TGFß cascade. DESIGN: Thirteen PA, 17 MEC, 13 ACC, and 10 non-neoplastic salivary gland samples were analyzed by real-time RT-PCR. RESULTS: Cases of PA presented increased TGFB1, LTPB1, c-MYC, and FBN1 expressions, whereas SMAD2 expression was decreased when compared to non-neoplastic tissue. MEC patients displayed increased expressions of TGFB1, ITGB6, FBN1, and c-MYC and decreased expressions of SMAD2 and SMAD4. ACC cases exhibited elevated expressions of the investigated genes except TGFB1. The present results suggest that decreased expression of SMAD2 and SMAD4 does not impede the transcriptional regulation of c-MYC, especially in PA and MEC. Increased expressions of ITGB6, TGFB1, LTBP1, and FBN1 appear to be related to the regulation of the TGFß signaling pathway in these tumors. Additionally, we observed a higher expression of SMAD4 in ACC and a raised expression of ITGB6 and lowered expression of SMAD2 in MEC. CONCLUSIONS: Our study demonstrated the differential expression of TGFß cascade members in salivary gland tumors such as SMAD2/SMAD4 and c-MYC as well as the participation of ITGB6, TGFB1, LTBP1, and FBN1, contributing to the understanding of the mechanisms involved in tumor progression.
Sujet(s)
Adénome pléomorphe , Carcinome adénoïde kystique , Carcinome mucoépidermoïde , Tumeurs des glandes salivaires , Facteur de croissance transformant bêta , Humains , Adénome pléomorphe/génétique , Adénome pléomorphe/métabolisme , Adénome pléomorphe/anatomopathologie , Marqueurs biologiques tumoraux/métabolisme , Carcinome adénoïde kystique/génétique , Carcinome adénoïde kystique/métabolisme , Carcinome mucoépidermoïde/métabolisme , Tumeurs des glandes salivaires/génétique , Tumeurs des glandes salivaires/métabolisme , Transduction du signal , Facteur de croissance transformant bêta/métabolismeRÉSUMÉ
BACKGROUND: Transcription factors are important in the epithelial-mesenchymal transition process and are possibly related to the development of a more invasive tumor phenotype. Thus, the objective of this study was to analyze the expression and identify the localization of cellular markers related to the epithelial-mesenchymal transition process in salivary gland tumors. STUDY DESIGN: The expression and localization of E-CADERIN, N-CADERIN, SLUG, SNAIL, and TWIST were evaluated, using immunohistochemistry, in 48 salivary gland tumors, being 17 pleomorphic adenomas (PA), 14 adenoid cystic carcinomas (ACC), and 17 mucoepidermoid carcinomas (MEC). these proteins were compared to clinical and histopathologic parameters. normal gland tissues were included for immunohistochemical comparisons. RESULTS: ACC and MEC cases showed higher expression of SNAIL compared to PA. MEC showed high expression of SLUG and TWIST. Low expression of N-CADHERIN, SNAIL, and TWIST in ACC was frequent in T3 and T4. High expression of TWIST in MEC was more frequent at age ≥ 40 years A positive correlation was only observed between N-cadherin/SNAIL in ACC, between SNAIL/TWIST in MEC, and between SLUG/TWIST in PA. CONCLUSION: This study provided insight into EMT-related proteins (E-cadherin, N-cadherin, SNAIL, SLUG, and TWIST) and their contribution to the maintenance of morphogenesis and the development of the salivary gland tumors and showed a positive correlation among N-CADHERIN/SNAIL in ACC and SNAIL/TWIST in MEC.
Sujet(s)
Adénome pléomorphe , Carcinome adénoïde kystique , Carcinome mucoépidermoïde , Tumeurs des glandes salivaires , Humains , Adulte , Facteurs de transcription de la famille Snail , Protéines nucléaires/génétique , Tumeurs des glandes salivaires/anatomopathologie , Carcinome adénoïde kystique/anatomopathologie , Carcinome mucoépidermoïde/anatomopathologie , Adénome pléomorphe/anatomopathologie , Cadhérines/génétique , Transition épithélio-mésenchymateuse/génétique , Marqueurs biologiques tumoraux , Protéine-1 apparentée à Twist/génétiqueRÉSUMÉ
B7-H4 (VTCN1), a member of the B7 family, is overexpressed in several types of cancer. Here we investigated the pattern of expression of B7-H4 in salivary gland carcinomas (SGC) and assessed its potential as a prognostic marker and therapeutic target. Immunohistochemistry (IHC) analyses were performed in a cohort of 340 patient tumors, composed of 124 adenoid cystic carcinomas (ACC), 107 salivary duct carcinomas (SDC), 64 acinic cell carcinomas, 36 mucoepidermoid carcinomas (MEC), 9 secretory carcinomas (SC), as well as 20 normal salivary glands (controls). B7-H4 expression was scored and categorized into negative (<5% expression of any intensity), low (5%-70% expression of any intensity or >70% with weak intensity), or high (>70% moderate or strong diffuse intensity). The associations between B7-H4 expression and clinicopathologic characteristics, as well as overall survival, were assessed. Among all tumors, B7-H4 expression was more prevalent in ACC (94%) compared with those of SC (67%), MEC (44%), SDC (32%), and acinic cell carcinomas (0%). Normal salivary gland tissue did not express B7-H4. High expression of B7-H4 was found exclusively in ACC (27%), SDC (11%), and MEC (8%). In SDC, B7-H4 expression was associated with female gender (P = .002) and lack of androgen receptor expression (P = .012). In ACC, B7-H4 expression was significantly associated with solid histology (P < .0001) and minor salivary gland primary (P = .02). High B7-H4 expression was associated with a poorer prognosis in ACC, regardless of clinical stage and histologic subtype. B7-H4 expression was not prognostic in the non-ACC SGC evaluated. Our comparative study revealed distinct patterns of B7-H4 expression according to SGC histology, which has potential therapeutic implications. B7-H4 expression was particularly high in solid ACC and was an independent prognostic marker in this disease but not in the other SGC assessed.
Sujet(s)
Tumeurs du sein , Carcinome à cellules acineuses , Carcinome adénoïde kystique , Carcinome mucoépidermoïde , Carcinomes , Tumeurs des glandes salivaires , Humains , Femelle , Carcinome adénoïde kystique/anatomopathologie , Pronostic , Carcinome à cellules acineuses/anatomopathologie , Tumeurs des glandes salivaires/anatomopathologie , Carcinome mucoépidermoïde/anatomopathologie , Carcinomes/anatomopathologie , Glandes salivaires/composition chimique , Glandes salivaires/métabolisme , Glandes salivaires/anatomopathologie , Marqueurs biologiques tumoraux/analyseRÉSUMÉ
BACKGROUND: There is no consensus about effective systemic therapy for salivary gland carcinomas (sgcs). Our aim was summarized the clinical trials assessing the systemic therapies (ST) on sgcs. MATERIAL AND METHODS: Electronic searches were carried out through MEDLINE/pubmed, EMBASE, Scopus, Web of Science, and the Cochrane Library databases, and gray literature. RESULTS: Seventeen different drugs were evaluated, and the most frequent histological subtype was adenoid cystic carcinoma (n=195, 45.5%). Stable disease, observed in 11 ST, achieved the highest rate in adenoid cystic carcinoma treated with sunitinib. The highest complete (11.1%) and partial response (30.5%) rates were seen in androgen receptor-positive tumors treated with leuprorelin acetate. CONCLUSIONS: Despite all the advances in this field, there is yet no effective evidence-based regimen of ST, with all the clinical trials identified showing low rates of complete and partial responses. Further, translational studies are urgently required to characterize molecular targets and effective ST.
Sujet(s)
Carcinome adénoïde kystique , Tumeurs des glandes salivaires , Humains , Carcinome adénoïde kystique/traitement médicamenteux , Tumeurs des glandes salivaires/traitement médicamenteux , Bases de données factuelles , Glandes salivairesRÉSUMÉ
PURPOSE: Amidst the rarity of High-grade transformation (HGT) in adenoid cystic carcinoma (ACC), this study offers unprecedented insights into its aggressive nature and clinical implications. METHODS: A 1:1 match comparison between 23 HGT patients and non-HGT counterparts was extracted from 412 ACC cases, focusing on dissecting distinctive clinicopathological features and prognostic outcomes. RESULTS: The predominant sites of HGT were the sinonasal and lacrimal glands (30.4% each). Notably, the solid subtype was the most prevalent pattern within HGT, accounting for 69.6% of cases. Compared to non-HGT, the HGT cohort exhibited significantly higher rates of lymph node metastasis (39.1% vs. 8.7%; P < 0.05), perineural invasion (60.9% vs. 26.1%; P < 0.05), and increased Ki-67 proliferation index (35.0% vs. 10.0%; P < 0.05). Moreover, HGT regions typically showed reduced or absent p63 expression, along with high-grade pathomorphology. HGT was associated with increased recurrence (55.0%) and distant metastasis (78.3%), leading to an average survival of 35.9 months and a 3-years mortality rate of 35.0%. Overall and progression-free survival rates were significantly decreased in the HGT group. CONCLUSION: This study represents the largest single-center cohort of HGT cases to our knowledge, highlighting its frequent occurrence in the sinonasal and lacrimal glands and association with poorer outcomes. The findings support classifying HGT in ACC as Grade 4, reflecting its severity.
Sujet(s)
Carcinome adénoïde kystique , Humains , Carcinome adénoïde kystique/anatomopathologie , Carcinome adénoïde kystique/mortalité , Mâle , Femelle , Adulte d'âge moyen , Pronostic , Chine/épidémiologie , Études cas-témoins , Adulte , Sujet âgé , Tumeurs de la tête et du cou/anatomopathologie , Tumeurs de la tête et du cou/mortalité , Grading des tumeurs , Transformation cellulaire néoplasique/anatomopathologie , Métastase lymphatique , Taux de survie , Invasion tumorale , Jeune adulteRÉSUMÉ
Adenoid cystic carcinoma (ACC) has been reported as the second most common carcinoma of the salivary glands. Few studies have associated miRNA expression with ACC aggressiveness. In this study, we evaluated the miRNA profile of formalin-fixed, paraffin-embedded (FFPE) samples of salivary gland ACC patients using the NanoString platform. We studied the miRNA expression levels associated with the solid growth pattern, the more aggressive histologic feature of ACCs, compared with the tubular and cribriform growth patterns. Moreover, the perineural invasion status, a common clinicopathological feature of the disease that is frequently associated with the clinical progression of ACC, was investigated. The miRNAs showing significant differences between the study groups were selected for target prediction and functional enrichment, which included associations with the disease according to dedicated databases. We observed decreased expression of miR-181d, miR-23b, miR-455, miR-154-5p, and miR-409 in the solid growth pattern compared with tubular and cribriform growth patterns. In contrast, miR-29c, miR-140, miR-195, miR-24, miR-143, and miR-21 were overexpressed in patients with perineural invasion. Several target genes of the miRNAs identified have been associated with molecular processes involved in cell proliferation, apoptosis, and tumor progression. Together, these findings allowed the characterization of miRNAs potentially associated with aggressiveness in salivary gland adenoid cystic carcinoma. Our results highlight important new miRNA expression profiles involved in ACC carcinogenesis that could be associated with the aggressive behavior of this tumor type.
Sujet(s)
Carcinome adénoïde kystique , microARN , Tumeurs des glandes salivaires , Humains , Carcinome adénoïde kystique/génétique , Carcinome adénoïde kystique/métabolisme , Carcinome adénoïde kystique/anatomopathologie , microARN/génétique , Tumeurs des glandes salivaires/génétique , Tumeurs des glandes salivaires/métabolisme , Tumeurs des glandes salivaires/anatomopathologie , Glandes salivaires/métabolisme , Carcinogenèse/génétiqueRÉSUMÉ
OBJECTIVE: Local recurrence, distant metastasis, and perineural invasion (PNI) viciously occur in salivary adenoid cystic carcinoma (SACC), resulting in a poor prognosis. This study aimed to explore the mechanism by which circular RNA RNF111 (circ-RNF111) regulates PNI in SACC by targeting the miR-361-5p/high mobility group box 2 (HMGB2) axis. METHOD: Circ-RNF111 and HMGB2 were highly expressed in SACC specimens, while miR-361-5p was underexpressed. Functional experiments showed that ablating circ-RNF111 or promoting miR-361-5p hindered the biological functions and PNI of SACC-LM cells. RESULTS: HMGB2 overexpression induced the reversal of SACC-LM cell biological functions and PNI caused by circ-RNF111 knockout. Furthermore, reduction of circ-RNF111 suppressed PNI in a SACC xenograft model. Circ-RNF111 regulated HMGB2 expression through targeted modulation of miR-361-5p. CONCLUSION: Taken together, circ-RNF111 stimulates PNI in SACC by miR-361-5p/HMGB2 axis and may serve as a potential therapeutic target for SACC.
Sujet(s)
Carcinome adénoïde kystique , microARN , Tumeurs des glandes salivaires , Humains , Carcinome adénoïde kystique/génétique , Carcinome adénoïde kystique/métabolisme , Carcinome adénoïde kystique/anatomopathologie , ARN circulaire/génétique , Protéine HMG2/génétique , Protéine HMG2/métabolisme , Tumeurs des glandes salivaires/génétique , Tumeurs des glandes salivaires/métabolisme , Tumeurs des glandes salivaires/anatomopathologie , Facteurs de transcription/métabolisme , microARN/génétique , microARN/métabolisme , Lignée cellulaire tumorale , Invasion tumorale/génétique , Régulation de l'expression des gènes tumoraux , Mouvement cellulaire/génétique , Prolifération cellulaire , Protéines nucléaires/métabolisme , Ubiquitin-protein ligases/génétique , Ubiquitin-protein ligases/métabolismeRÉSUMÉ
BACKGROUND: Autophagy is a cellular survival mechanism involved in several human diseases, but its participation in the development of salivary gland tumors is not fully understood. This study investigated the immunoexpression of autophagy-related proteins (autophagy-related 7 [Atg7], microtubule-associated protein 1 light chain 3A [LC3A], microtubule-associated protein 1 light chain 3B [LC3B], protein p62 [p62], and phosphorylated mammalian target of rapamycin [p-mTOR]) in pleomorphic adenoma (PA), polymorphous adenocarcinoma (PAC), mucoepidermoid carcinoma (MEC), and adenoid cystic carcinoma (ACC) of salivary glands. METHODS: Twenty PAs, 20 PACs, 20 MECs, and 14 ACCs were selected. The percentages of cytoplasmic and nuclear positivity for autophagy-related proteins in neoplastic cells were assessed and correlated with histopathological parameters. RESULTS: Cytoplasmic immunoexpression of Atg7 was observed in all groups, with high median percentages of positivity. Regarding LC3A and LC3B, cytoplasmic immunoexpression was found in most PACs (95%) and in all cases of PA, MEC and ACC, with the highest percentages of positivity in PACs and PAs (p < 0.005). ACCs exhibited lower cytoplasmic immunoexpression of p-mTOR (p < 0.005) and lower nuclear expression of p62 (p < 0.05) when compared to PAs, PACs and MECs. Low nuclear immunoexpression of Atg7, LC3A and p-mTOR and absence of nuclear staining for LC3B were observed in all groups. Regarding histopathological parameters of PAs, MECs and ACCs, there were no significant differences in the expression of autophagy-related proteins. In all groups, positive correlations were observed between the immunoexpression of some autophagy-related proteins (p < 0.05). CONCLUSIONS: The results suggest the participation of autophagy in the pathogenesis of PA, PAC, MEC, and ACC of salivary glands. Upregulation of autophagy and reduced nuclear translocation of p62 may contribute to the aggressive biological behavior of salivary gland ACC.
Sujet(s)
Adénocarcinome , Adénome pléomorphe , Carcinome adénoïde kystique , Carcinome mucoépidermoïde , Tumeurs des glandes salivaires , Humains , Protéines associées à l'autophagie , Immunohistochimie , Tumeurs des glandes salivaires/anatomopathologie , Glandes salivaires/métabolisme , Adénome pléomorphe/anatomopathologie , Carcinome adénoïde kystique/anatomopathologie , Adénocarcinome/anatomopathologie , Carcinome mucoépidermoïde/anatomopathologie , Marqueurs biologiques tumoraux/métabolismeRÉSUMÉ
OBJECTIVE: To describe the frequency, clinical, and demographic features of minor salivary gland tumors and possible associated factors. MATERIALS AND METHODS: A cross-sectional study was conducted. Clinical and demographic data were collected from biopsy records of two oral pathology services. Chi-square test, Fisher's exact test, and descriptive statistical analysis were performed. RESULTS: A total of 480 (0.89%) minor salivary gland tumors were retrieved, 272 (56.7%) benign and 147 (30.7%) malignant. Sixty-one (12.6%) had no subtype specification. Most patients were women (307/64.0%), in sixth decade of life (80/16.7%), with a mean age of 45.32 years. Palate was the most common site (336/70.1%). Pleomorphic adenoma (PA; 245/51.1%), mucoepidermoid carcinoma (MEC; 70/14.6%), and adenoid cystic carcinoma (ACC; 43/8.9%) were the most frequent tumors. Symptomatic case, recurrence, and tobacco use were associated with malignancy (p < 0.05). PA and MEC were more frequent in palate (p < 0.05). No association between the three most frequent histological types and gender or age group was observed (p > 0.05). CONCLUSIONS: This represents one of the largest exclusive series of minor salivary gland tumors in Brazil and worldwide. PA, MEC, and ACC were the most frequent tumors. Clinical and demographic data are similar from Brazilian studies or from other countries.
Sujet(s)
Adénome pléomorphe , Carcinome adénoïde kystique , Tumeurs des glandes salivaires , Humains , Femelle , Adulte d'âge moyen , Mâle , Études transversales , Glandes salivaires mineures , Tumeurs des glandes salivaires/épidémiologie , Tumeurs des glandes salivaires/anatomopathologie , Adénome pléomorphe/épidémiologie , Adénome pléomorphe/anatomopathologie , Carcinome adénoïde kystique/épidémiologie , Carcinome adénoïde kystique/anatomopathologie , Démographie , Études rétrospectivesRÉSUMÉ
BACKGROUND: Mitochondrial fission and fusion processes are known as mitochondrial dynamics and the occurrence of imbalances in the mitochondrial activity is related to the pathogenesis of many human cancers. However, the importance of mitochondrial dynamics in malignant salivary gland tumours remains unknown. Therefore, we aimed to investigate its prognostic significance in adenoid cystic carcinoma. METHODS: Fifty-seven formalin-fixed paraffin-embedded cases were retrieved and disposed in tissue microarray. Histological sections were submitted to immunohistochemical reactions against AMT, DRP1, FIS1, MFN1, MFN2 and OPA1 proteins. Clinical data were retrieved from the patients' medical files, including specific and disease-free survival data. RESULTS: It was observed that 50.9% of the cases were strongly positive for AMT and DRP1, and 49.1%, 21.1%, 22.8% and 24.6% strongly positive for FIS1, MFN1, MFN2 and OPA1, respectively. Reactions were observed in both epithelial and myoepithelial components of the tumour. The higher expression of MFN2 was associated with solid microscopic pattern (p = 0.016). DRP1 overexpression showed a trend towards a shorter overall survival (p = 0.054), while negative/weak OPA1 showed a trend towards a lower disease-free survival (p = 0.051) in the univariate analysis, but no mitochondrial marker represented an independent prognostic determinant under multivariate analysis. CONCLUSION: In conclusion, mitochondrial dynamics markers do not seem to carry a prognostic significance for adenoid cystic carcinoma patients, but these proteins may play an important role in its pathogenesis.
Sujet(s)
Carcinome adénoïde kystique , Dynamique mitochondriale , Carcinome adénoïde kystique/métabolisme , Humains , MitochondriesRÉSUMÉ
Introducción: El carcinoma adenoide quístico es una neoplasia maligna poco común y a menudo agresiva, que puede surgir en una variedad de órganos portadores de glándulas. Objetivo: Caracterizar la presentación de una neoplasia maligna agresiva infrecuente, el carcinoma adenoide quístico. Caso clínico: Paciente de 56 años que acudió a cuerpo de guardia con lesión en cuero cabelludo correspondiente con cilindroma maligno. Se estudia posteriormente y se constataron además lesiones a nivel de mamas, colon y recidiva en el cuero cabelludo, que dieron como resultado carcinoma adenoide quístico. Conclusiones: Es infrecuente; realizar su diagnóstico conlleva un alto índice de sospecha y su diagnóstico es histopatológico. Su pronóstico depende de la localización primaria y tiende a ser muy agresivo cuando se localiza fuera de la mama(AU)
Introduction: Adenoid cystic carcinoma is an uncommon and often aggressive malignant neoplasm that can arise in a variety of gland-bearing organs. Objective: To characterize the presentation of an uncommon aggressive malignancy, adenoid cystic carcinoma. Clinical case: 56-year-old patient who presented to the on-call department with a lesion on the scalp corresponding to malignant cylindroma. She was subsequently studied and lesions were also found in the breast, colon and recurrence in the scalp, which resulted in adenoid cystic carcinoma. Conclusions: It is infrequent; making its diagnosis involves a high index of suspicion and its diagnosis is histopathological. Its prognosis depends on the primary location and it tends to be very aggressive when located outside the breast(AU)
Sujet(s)
Humains , Femelle , Adulte d'âge moyen , Tumeurs du sein/diagnostic , Carcinome adénoïde kystique/diagnosticRÉSUMÉ
Primary cystic adenoid skin carcinoma is a rare and poorly documented neoplasm in literature worldwide, with just over 250 reports. This work describes a 52-year-old male patient, with no comorbidities, who presented this neoplasm in nodular format in the posterior thoracic region, associated with localized pain and erythema - symptoms that led him to seek medical help. The clinical findings, differential diagnosis and treatment particularities were reviewed and correlated with the clinical case. The choice of type of surgical treatment was done considering the characteristics of the primary lesion that are associated with a worse prognosis. Despite its rarity, this neoplasm is easily identified through histological examination, the correct choice of treatment and patient follow-up, essential to increase survival. Thus, this work contributes to diminish the scarcity of literature related to this topic, especially the form of treatment employed.
Sujet(s)
Carcinome adénoïde kystique , Carcinome adénoïde kystique/diagnostic , Carcinome adénoïde kystique/anatomopathologie , Carcinome adénoïde kystique/thérapie , Diagnostic différentiel , Humains , Mâle , Adulte d'âge moyen , PronosticRÉSUMÉ
Objetivos: O carcinoma adenoide cístico é uma lesão rara e agressiva. O presente trabalho visa relatar o caso de uma ressecção de carcinoma adenoide cístico e manutenção do arcabouço ósseo realizado por meio de sonda de Foley insuflada com soro fisiológico. Relato do caso: Um paciente submetido a ressecação de um carcinoma adenoide cístico em maxilla com destruição de soalho de órbita foi relatado. O caso foi realizado no Hospital Josina Machel em Luanda, Angola. A região apresenta uma considerável escassez de materiais de fixação e outros mais, o que impossibilita reconstruções maxilofaciais com a excelência necessária. A realização de enxertos microvascularizados ou implantes customizados torna-se inviável devido aos custos e tecnologia dispendida para tal. Conclusão: A sonda de Foley mostra-se como uma alternativa viável nos casos de reconstrução de terço médio de face com envolvimento de seio maxilar e soalho de órbita em locais de mais difícil acesso... (AU)
Objectives: Adenoid cystic carcinoma is a rare and aggressive lesion. The present work aims to report the case of a resection of adenoid cystic carcinoma and maintenance of the bone framework performed using a Foley catheter insufflated with saline solution. Case report: A patient who underwent resection of an adenoid cystic carcinoma in the maxilla with destruction of the orbital floor was reported. The case was carried out at Hospital Josina Machel in Luanda, Angola. The region has a considerable shortage of fixation materials and others, which makes maxillofacial reconstructions with the necessary excellence impossible. The realization of microvascularized grafts or customized implants becomes unfeasible due to the costs and technology used for this purpose. Conclusion: The Foley catheter is a viable alternative in cases of reconstruction of the middle third of the face with involvement of the maxillary sinus and orbital floor in areas that are more difficult to access... (AU)
Objetivos: El carcinoma adenoide quístico es una lesión rara y agresiva. El presente trabajo tiene como objetivo reportar el caso de una resección de carcinoma quístico adenoide y mantenimiento de la estructura ósea realizada mediante sonda de Foley insuflada con suero fisiológico. Caso clínico: Se reporta un paciente que fue sometido a resección de un carcinoma adenoide quístico en el maxilar con destrucción del piso orbitario. El caso se llevó a cabo en el Hospital Josina Machel de Luanda, Angola. La región tiene una escasez considerable de materiales de fijación y otros, lo que imposibilita las reconstrucciones maxilofaciales con la excelencia necesaria. La realización de injertos microvascularizados o implantes personalizados se vuelve inviable por los costes y la tecnología utilizada para tal fin. Conclusión: La sonda de Foley es una alternativa viable en los casos de reconstrucción del tercio medio de la cara con afectación del seno maxilar y suelo orbitario en zonas de más difícil acceso... (AU)
Sujet(s)
Humains , Femelle , Adulte d'âge moyen , Orbite/chirurgie , Orbite/anatomopathologie , Tumeurs des sinus maxillaires , Tumeurs de la mâchoire , Carcinome adénoïde kystique , Sinus maxillaire , Plaies et blessuresRÉSUMÉ
INTRODUCTION: Malignant tumors of the salivary glands are uncommon pathological entities, representing less than 5% of head and neck neoplasms. The prognosis of patients with malignant tumors of the salivary glands is highly variable and certain clinical factors can significantly influence overall survival. OBJECTIVE: To analyze the clinicopathologic and sociodemographic characteristics that influence survival in patients with malignant tumors of the salivary glands METHODS: This retrospective study analyzed sex, age, race, education level, tumor location, tumor size, lymph node involvement, distant metastasis, margin status, treatment type, marital status, method of health care access and 15-year overall survival in 193 patients with malignant tumors of the salivary glands. The X², log-rank Mantel-Cox, multinomial regression and Cox logistic regression tests were used (SPSS 20.0,p < 0.05). RESULTS: The most common histological types were adenocarcinoma (32.1%), adenoid cystic carcinoma (31.1%) and mucoepidermoid carcinoma (18.7%). The 15-year overall survival rate was 67.4%, with a mean of 116±6 months. The univariate analysis revealed that male sex (p = 0.026), age > 50 years (p=0.001), referral origin from the public health system (p=0.011), T stage (p= 0.007), M stage (p< 0.001), clinical stage (p< 0.001), compromised surgical margins (p= 0.013), and chemotherapy (p< 0.001) were associated with a poor prognosis. Multivariate analyses also showed that age > 50 years was independently associated with a poor prognosis (p= 0.016). The level of education was the only factor more prevalent in older patients (p= 0.011). CONCLUSION: Patients with malignant tumors of the salivary glands older than 50 years have a worse prognosis and an independent association with a low education level.
Sujet(s)
Adénocarcinome , Carcinome adénoïde kystique , Carcinome mucoépidermoïde , Tumeurs des glandes salivaires , Adénocarcinome/mortalité , Adénocarcinome/anatomopathologie , Adénocarcinome/thérapie , Facteurs âges , Sujet âgé , Carcinome adénoïde kystique/mortalité , Carcinome adénoïde kystique/anatomopathologie , Carcinome adénoïde kystique/thérapie , Carcinome mucoépidermoïde/mortalité , Carcinome mucoépidermoïde/thérapie , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Pronostic , Études rétrospectives , Tumeurs des glandes salivaires/mortalité , Tumeurs des glandes salivaires/anatomopathologie , Tumeurs des glandes salivaires/thérapie , Facteurs sexuels , Facteurs sociodémographiques , Taux de survieRÉSUMÉ
Os tumores de glândula salivar (TGS) representam cerca de 3% a 6% das neoplasias da região de cabeça e pescoço e são caracterizados por sua diversidade morfológica e de comportamentos biológicos. Sabe-se que algumas das características de tumores malignos, como a invasão tumoral e metástases à distância, possuem envolvimento da transição epitélio-mesênquima (TEM), evento no qual proteínas como a E-caderina, Snail1 e Vimentina estão diretamente envolvidas. Esta pesquisa se propôs a analisar e relacionar a expressão imuno-histoquímica dessas proteínas com as características clínico-patológicas em adenomas pleomórficos (APs), carcinomas adenoides císticos (CACs) e carcinomas ex-adenomas pleomórficos (CaExAPs) de glândulas salivares maiores e menores. A análise da imunoexpressão dessas proteínas foi feita de forma semiquantitativa em 20 casos de APs, 20 de CACs e 10 de CaExAPs. Na avaliação de E-caderina, considerou-se a expressão em membrana e/ou citoplasma das células do parênquima tumoral. Para a Snail1, foi considerada a expressão nos compartimentos nuclear e/ou citoplasmático dessas células. A Vimentina foi analisada no citoplasma de células fusiformes presentes no estroma dos TGS. Os dados obtidos foram comparados e correlacionados utilizando o nível de significância de 5% (p ≤ 0,05). Observou-se imunopositividade para E-caderina principalmente em citoplasma das células neoplásicas nãoluminais; a marcação membranar, perceptível em células luminais, estava mais presente nas neoplasias malignas (p = 0,041). A expressão de Snail1 foi mais frequente no compartimento nuclear, sendo mais evidenciada em células não-luminais dos TGS e apresentou maior reatividade nuclear em tumores malignos (p = 0,012). A expressão nuclear dessa proteína também foi maior para CACs e CaExAPs ao compará-los, de forma separada, com os APs (p = 0,037 e p = 0,025, respectivamente). Não foram observadas diferenças estatisticamente significativas entre a expressão de E-caderina e Snail1 e outros parâmetros clinico-patológicos e os subtipos histopatológicos das lesões (p > 0,05). A positividade para Vimentina foi vista no estroma de todos os casos de TGS, sendo mais difusa e intensa em CACs. Não foram verificadas diferenças estatisticamente significativas entre a expressão desse biomarcador e os parâmetros clínico-patológicos e subtipos histopatológicos das lesões (p > 0,05). Houve correlações positivas entre as expressões membranar e citoplasmática de E-caderina em APs, CACs e CaExAPs (r = 0,645, p = 0,002; r = 0,781, p < 0,001; r = 0,677 p = 0,031), bem como entre a expressão nuclear e citoplasmática de Snail1 e a expressão citoplasmática de E-caderina e nuclear de Snail1 em APs (r = 0,569, p = 0,009; r = 0,481, p = 0,032). Foram verificadas correlações negativas entre a expressão membranar de E-caderina e citoplasmática de Snail1, bem como entre Snail1 nuclear e Vimentina em CACs (r = -0,471, p = 0,036; r = -0,514; p = 0,021). Essa última correlação, bem como correlação positiva entre a expressão membranar e citoplasmática de E-caderina, também foi vista entre os casos de CACs e CaExAPs quando agrupados (r = -0,457; p = 0,0011; r = 0,746, p < 0,001). Os resultados do presente estudo sugerem que a participação de E-caderina e Snail1 no processo da TEM pode estar relacionada ao estágio de diferenciação celular em APs e à progressão tumoral nas neoplasias malignas bem como é possível que a expressão dessas proteínas em neoplasias malignas seja indicativa da plasticidade presente na TEM. Ressalta-se, também, a expressão de Vimentina em células fusiformes presentes no estroma tumoral, provavelmente refletindo estágios tardios da TEM (AU).
Salivary gland tumors (SGTs) comprise about 2% to 10% of head and neck tumors and are known for their morphologic diversity and biologic behavior. Some features of malignant neoplasms, such as tumor invasion and distant metastasis, might have the participation of epithelial-mesenchymal transition (EMT), event in which proteins like E-cadherin, Vimentin and Snail1 are directly involved. This study aimed to analyze, by means of immunohistochemistry, the expression of these proteins, as well as to relate their expressions to clinical-pathological features of pleomorphic adenomas (PAs), adenoid cystic carcinomas (ACCs) and carcinomas ex-pleomorphic adenomas (CXPAs) located in minor and major salivary glands. This was a semi-quantitatively analysis which comprised 20 PAs, 20 ACCs and 10 CXPAs. Analysis of E-cadherin was made considering membranar and/or cytoplasmatic expression in parenchymal cells. For Snail1, it was considered the positivity in nucleus and/or cytoplasm of parenchymal cells. Vimentin was evaluated in the cytoplasm of fusiform stromal cells. Data were compared and correlated adopting a level of significance of 5% (p ≤ 0,05). Marked immunoexpression for E-cadherin was mostly found in the cytoplasm of non-luminal neoplastic cells in SGTs; membrane reaction for the protein, seen in luminal cells, was higher in malignant tumors (p = 0,041). Snail1 was more expressed in the nucleus, mostly of nonluminal cells of SGTs, with this reactivity being higher in malignant tumors(p = 0,012). Nuclear positivity for this marker was also higher for ACCs and CXPAs when compared with PAs separately (p = 0,037 e p = 0,025, respectively). No significant differences between E-cadherin and Snail1 and other clinical-pathological parameters were found (p > 0,05). Vimentin was seen in the stroma of all cases, being more diffuse and intense in ACCs. No significant differences between this marker and clinical-pathological parameters were found (p > 0,05). Positive correlations between membranar and cytoplasmatic E-cadherin in PAs, ACCs and CXPAs were observed (r = 0,645, p = 0,002; r = 0,781, p < 0,001; r = 0,677 p = 0,031), as well as between nuclear and cytoplasmatic Snail1 and between cytoplasmatic E-cadherin and nuclear Snail1 in PAs APs (r = 0,569, p = 0,009; r = 0,481, p = 0,032). Negative correlations between membranar E-cadherin and cytoplasmatic Snail1 were observed, as well as between nuclear Snail1 and Vimentin in ACCs (r = -0,471, p = 0,036; r = -0,514; p = 0,021). This last correlation and a positive correlation between membranar and cytoplasmatic E-cadherin were also seen when ACCs and CXPAs were grouped (r = -0,457; p = 0,0011; r = 0,746, p < 0,001). These results suggest that the participation of these proteins in EMT might be related to cellular differentiation in PAs and to tumoral progression in malignant tumors. In addition, it can be infered that the expression of E-cadherin and Snail1 in malignant tumors might reflect the plasticity seen in EMT process. Furthermore, the expression of Vimentin in fusiform stromal cells, probably in later stages of EMT, in the stroma of SGTs, is highlighted (AU).